On April 4, 2024, upon the recommendation of the Company's Nominating and Governance Committee, the Board of Directors of Nutex Health Inc., to fill the vacancy created by the passing of John Waters, an independent director of the Company, appointed Scott J. Saunders, age 61, to serve as a director of the Company for a term commencing on April 11, 2024 and expiring at the Annual Meeting of Stockholders of the Company in 2024 and until his successor is duly elected and qualifies, unless he sooner dies, retires or resigns. Mr. Saunders is head of health care advisory services and has been Managing Director of Farlie Turner Gilbert & Co., LLC, a boutique middle market investment bank in Fort Lauderdale, Florida, since 2006. Since 1992, he has served as a financial and strategic advisor to middle market companies across a variety of industries, including companies primarily in the healthcare industry as well as those in financial distress.

In addition, he advised companies in the media and communications, business services, industrial, and consumer products industries. He has been a guest lecturer at the University of Florida and Florida International University. In addition, he co-taught a class in management consulting to undergraduates and graduate students in the Management Department at the University of Miami.

He is a frequent panelist at industry conferences on topics in healthcare M&A and financing. Throughout his career, he has developed relationships with key representatives of leading middle market private equity and private credit firms, as well as mezzanine capital firms, BDCs, and selected hedge funds. Mr. Saunders received his B.A. degree from Wesleyan University and his MPPM degree from the Yale University School of Management.

The Company believes that Mr. Saunders's background and experience in healthcare advisory roles make him well qualified to serve as a director.